Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients

被引：0
|
作者：
Lange, Thoralf
Edelmann, Anja
Siebolts, Uwe [1 ]
Nehring, Claudia
Jaeckel, Nadja
Cross, Michael
Jacqueline, Maier
Niederwieser, Dietger
Wickenhauser, Claudia [1 ]
机构：
[1] Univ Clin, Inst Pathol, Leipzig, Germany
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1421 / 1421
页数：1
相关论文
共 50 条
  • [21] Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden
    Lee, A-Jin
    Kim, Sang-Gyung
    Nam, Jun Yeb
    Yun, Jaehum
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    BLOOD RESEARCH, 2021, 56 (04) : 259 - 265
  • [22] Comparison of JAK2 V617F positive and negative myeloproliferative diseases
    Szilvasi, A.
    Andrikovics, H.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 379 - 379
  • [23] Gender Is a Phenotypic Modifier in the JAK2 V617F-Positive MPD
    Stein, Brady L.
    Williams, Donna
    Rogers, Ophelia
    Isaacs, Mary Ann
    Pemmaraju, Naveen
    Moliterno, Alison R.
    BLOOD, 2008, 112 (11) : 622 - 622
  • [24] Clinical characteristics of JAK2 V617F positive myeloproliferative diseases
    Andrikovics, H.
    Szilvasi, A.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    BLOOD REVIEWS, 2007, 21 : S124 - S124
  • [25] JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the "hypermutability" hypothesis?
    Stolyar, M. A.
    Klimova, O. A.
    Gorbenko, A. S.
    Brenner, E. V.
    Titov, S. E.
    Ivanov, M. K.
    Olkhovskiy, I. A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : E8 - E10
  • [26] TARGETING OF BRD4 AS A NOVEL THERAPEUTIC CONCEPT IN JAK2 V617F+MPN
    Keller, A.
    Peter, B.
    Zuber, J.
    Berger, D.
    Staber, P. B.
    Bettelheim, P.
    Valent, P.
    Hadzijusufovic, E.
    HAEMATOLOGICA, 2016, 101 : 89 - 89
  • [27] Evaluation of BRD4 as potential target in JAK2 V617F+MPN cells
    Keller, A.
    Peter, B.
    Zuber, J.
    Valent, P.
    Hadzijusufovic, E.
    Oncology Research and Treatment, 2015, 38 : 226 - 227
  • [28] 不同MPN JAK2～(V617F)突变的临床检测方法比较
    丁忠奇
    李毅
    郑国华
    中国医学工程, 2013, 21 (05) : 96 - 97
  • [29] Pitpβ Loss Ameliorates Jak2 V617F-Induced Myeloproliferative Neoplasms (MPN) in Mice
    Vantsev, Nikita
    Zhao, Liang
    Abrams, Charles S.
    Tong, Wei
    BLOOD, 2024, 144 : 1753 - 1754
  • [30] A GERMLINE JAK2 SNP IS ASSOCIATED WITH PREDISPOSITION TO THE DEVELOPMENT OF JAK2 V617F-POSITIVE MYELOPROLIFERATIVE NEOPLASMS
    Kilpivaara, M.
    Mukherjee, S.
    Schram, M.
    Wadleigh, M.
    Mullally, A.
    Ebert, L.
    Bass, A.
    Marubayashi, S.
    Heguy, A.
    Garcia-Manero, G.
    Kantarjian, H.
    Offit, K.
    Stone, M.
    Gilliland, D.
    Klein, J.
    Levine, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 420 - 420
12345